Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015 (2015), Article ID 916585, 9 pages
http://dx.doi.org/10.1155/2015/916585
Review Article

Estrogen: An Emerging Regulator of Insulin Action and Mitochondrial Function

1Bioenergetics Laboratory, Houston Methodist Research Institute, Weill Cornell Medical College, 6565 Fannin Street, Houston, TX 77030, USA
2Atherosclerosis & Lipoprotein Research, Methodist DeBakey Heart and Vascular Institute, Houston Methodist Research Institute, Weill Cornell Medical College, 6565 Fannin Street, Houston, TX 77030, USA
3Houston Methodist Department of Medicine, Weill Cornell Medical College, 6550 Fannin, Suite 1001, Houston, TX 77030, USA

Received 31 December 2014; Accepted 10 March 2015

Academic Editor: Eirik Søfteland

Copyright © 2015 Anisha A. Gupte et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Carr, “The emergence of the metabolic syndrome with menopause,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 6, pp. 2404–2411, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. J. E. Rossouw, G. L. Anderson, R. L. Prentice et al., “Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial,” Journal of the American Medical Association, vol. 288, no. 3, pp. 321–333, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. S. R. Salpeter, J. M. E. Walsh, T. M. Ormiston, E. Greyber, N. S. Buckley, and E. E. Salpeter, “Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women,” Diabetes, Obesity and Metabolism, vol. 8, no. 5, pp. 538–554, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Pentti, M. T. Tuppurainen, R. Honkanen et al., “Hormone therapy protects from diabetes: the Kuopio osteoporosis risk factor and prevention study,” European Journal of Endocrinology, vol. 160, no. 6, pp. 979–983, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. M. Kanaya, D. Herrington, E. Vittinghoff et al., “Glycemic effects of postmenopausal hormone therapy: the heart and estrogen/progestin replacement study: a randomized, double-blind, placebo-controlled trial,” Annals of Internal Medicine, vol. 138, no. 1, pp. 1–9, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. K. L. Margolis, D. E. Bonds, R. J. Rodabough et al., “Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: Results from the Women's Health Initiative Hormone Trial,” Diabetologia, vol. 47, no. 7, pp. 1175–1187, 2004. View at Google Scholar · View at Scopus
  7. E. D. Szmuilowicz, C. A. Stuenkel, and E. W. Seely, “Influence of menopause on diabetes and diabetes risk,” Nature Reviews Endocrinology, vol. 5, no. 10, pp. 553–558, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. S. R. Lindheim, S. C. Presser, E. C. Ditkoff, M. A. Vijod, F. Z. Stanczyk, and R. A. Lobo, “A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin,” Fertility and Sterility, vol. 60, no. 4, pp. 664–667, 1993. View at Google Scholar · View at Scopus
  9. S. C. Hewitt and K. S. Korach, “Estrogen receptors: structure, mechanisms and function,” Reviews in Endocrine and Metabolic Disorders, vol. 3, no. 3, pp. 193–200, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Yi, S. Bhagat, R. Hilf, R. A. Bambara, and M. Muyan, “Differences in the abilities of estrogen receptors to integrate activation functions are critical for subtype-specific transcriptional responses,” Molecular Endocrinology, vol. 16, no. 8, pp. 1810–1827, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. E. R. Prossnitz and M. Barton, “The G-protein-coupled estrogen receptor GPER in health and disease,” Nature Reviews Endocrinology, vol. 7, no. 12, pp. 715–726, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. C. M. Revankar, D. F. Cimino, L. A. Sklar, J. B. Arterburn, and E. R. Prossnitz, “A transmembrane intracellular estrogen receptor mediates rapid cell signaling,” Science, vol. 307, no. 5715, pp. 1625–1630, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. C. J. Park, Z. Zhao, C. Glidewell-Kenney et al., “Genetic rescue of nonclassical ERalpha signaling normalizes energy balance in obese Eralpha-null mutant mice,” Journal of Clinical Investigation, vol. 121, no. 2, pp. 604–612, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. T.-S. Wu and G. L. Hammond, “Naturally occurring mutants inform SHBG structure and function,” Molecular Endocrinology, vol. 28, no. 7, pp. 1026–1038, 2014. View at Publisher · View at Google Scholar
  15. E. L. Ding, Y. Song, J. E. Manson et al., “Sex hormone-binding globulin and risk of type 2 diabetes in women and men,” The New England Journal of Medicine, vol. 361, no. 12, pp. 1152–1163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Mauvais-Jarvis, D. J. Clegg, and A. L. Hevener, “The role of estrogens in control of energy balance and glucose homeostasis,” Endocrine Reviews, vol. 34, no. 3, pp. 309–338, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Bryzgalova, H. Gao, B. Ahren et al., “Evidence that oestrogen receptor-α plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver,” Diabetologia, vol. 49, no. 3, pp. 588–597, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. P. A. Heine, J. A. Taylor, G. A. Iwamoto, D. B. Lubahn, and P. S. Cooke, “Increased adipose tissue in male and female estrogen receptor-α knockout mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 23, pp. 12729–12734, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Ogawa, J. Chan, J.-Å. Gustafsson, K. S. Korach, and D. W. Pfaff, “Estrogen increases locomotor activity in mice through estrogen receptor α: specificity for the type of activity,” Endocrinology, vol. 144, no. 1, pp. 230–239, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Lundholm, G. Bryzgalova, H. Gao et al., “The estrogen receptor alpha-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms,” Journal of Endocrinology, vol. 199, no. 2, pp. 275–286, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Foryst-Ludwig, M. Clemenz, S. Hohmann et al., “Metabolic actions of estrogen receptor beta (ERβ) are mediated by a negative cross-talk with PPARγ,” PLoS Genetics, vol. 4, no. 6, Article ID e1000108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Zirilli, V. Rochira, C. Diazzi, G. Caffagni, and C. Carani, “Human models of aromatase deficiency,” Journal of Steroid Biochemistry and Molecular Biology, vol. 109, no. 3–5, pp. 212–218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Maffei, Y. Murata, V. Rochira et al., “Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 1, pp. 61–70, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. R. P. A. Barros, C. Gabbi, A. Morani, M. Warner, and J.-Å. Gustafsson, “Participation of ERα and ERβ in glucose homeostasis in skeletal muscle and white adipose tissue,” American Journal of Physiology—Endocrinology and Metabolism, vol. 297, no. 1, pp. E124–E133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. R. P. A. Barros, U. F. Machado, M. Warner, and J.-Å. Gustafsson, “Muscle GLUT4 regulation by estrogen receptors ERβ and ERα,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 5, pp. 1605–1608, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. B. K. Gorres, G. L. Bomhoff, A. A. Gupte, and P. C. Geiger, “Altered estrogen receptor expression in skeletal muscle and adipose tissue of female rats fed a high-fat diet,” Journal of Applied Physiology, vol. 110, no. 4, pp. 1046–1053, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. B. K. Gorres, G. L. Bomhoff, J. K. Morris, and P. C. Geiger, “In vivo stimulation of oestrogen receptor α increases insulin-stimulated skeletal muscle glucose uptake,” Journal of Physiology, vol. 589, no. 8, pp. 2041–2054, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Zhu, M. N. Martinez, C. H. Emfinger, B. T. Palmisano, and J. M. Stafford, “Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity,” American Journal of Physiology—Endocrinology and Metabolism, vol. 306, no. 10, pp. E1188–E1197, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Nigro, A. T. Santos, C. S. Barthem et al., “A change in liver metabolism but not in brown adipose tissue thermogenesis is an early event in ovariectomy-induced obesity in rats,” Endocrinology, vol. 155, no. 8, pp. 2881–2891, 2014. View at Publisher · View at Google Scholar
  30. V. Ribas, M. T. A. Nguyen, D. C. Henstridge et al., “Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERα-deficient mice,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 298, no. 2, pp. E304–E319, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Ribas, B. G. Drew, J. A. Le et al., “Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 39, pp. 16457–16462, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. D. J. Clegg, L. M. Brown, S. C. Woods, and S. C. Benoit, “Gonadal hormones determine sensitivity to central leptin and insulin,” Diabetes, vol. 55, no. 4, pp. 978–987, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Yonezawa, T. Wada, N. Matsumoto et al., “Central versus peripheral impact of estradiol on the impaired glucose metabolism in ovariectomized mice on a high-fat diet,” American Journal of Physiology: Endocrinology and Metabolism, vol. 303, no. 4, pp. E445–E456, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Le May, K. Chu, M. Hu et al., “Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 24, pp. 9232–9237, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Liu and F. Mauvais-Jarvis, “Rapid, nongenomic estrogen actions protect pancreatic islet survival,” Islets, vol. 1, no. 3, pp. 273–275, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Yang, Y. Park, H. Zhang et al., “Feed-forward signaling of TNF-alpha and NF-kappaB via IKK-beta pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 296, no. 6, pp. H1850–H1858, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Li and X. Yu, “Emerging role of JNK in insulin resistance,” Current Diabetes Reviews, vol. 9, no. 5, pp. 422–428, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. R. López-Grueso, J. Gambini, K. M. Abdelaziz et al., “Early, but not late onset estrogen replacement therapy prevents oxidative stress and metabolic alterations caused by Ovariectomy,” Antioxidants and Redox Signaling, vol. 20, no. 2, pp. 236–246, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Haas, I. Bhattacharya, E. Brailoiu et al., “Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity,” Circulation Research, vol. 104, no. 3, pp. 288–291, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Riant, A. Waget, H. Cogo, J.-F. Arnal, R. Burcelin, and P. Gourdy, “Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice,” Endocrinology, vol. 150, no. 5, pp. 2109–2117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. X. P. Yang and J. F. Reckelhoff, “Estrogen, hormonal replacement therapy and cardiovascular disease,” Current Opinion in Nephrology and Hypertension, vol. 20, no. 2, pp. 133–138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Karim, W. J. Mack, H. N. Hodis, S. Roy, and F. Z. Stanczyk, “Influence of age and obesity on serum estradiol, estrone, and sex hormone binding globulin concentrations following oral estrogen administration in postmenopausal women,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 11, pp. 4136–4143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Garrido, F. Salehzadeh, D. E. Duque-Guimaraes, and L. Al-Khalili, “Negative regulation of glucose metabolism in human myotubes by supraphysiological doses of 17β-estradiol or testosterone,” Metabolism, vol. 63, no. 9, pp. 1178–1187, 2014. View at Publisher · View at Google Scholar
  44. E. R. Simpson, M. Misso, K. N. Hewitt et al., “Estrogen—the good, the bad, and the unexpected,” Endocrine Reviews, vol. 26, no. 3, pp. 322–330, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. W. B. Kannel and P. W. F. Wilson, “Risk factors that attenuate the female coronary disease advantage,” Archives of Internal Medicine, vol. 155, no. 1, pp. 57–61, 1995. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Lind, A. M. Svensson, M. Kosiborod et al., “Glycemic control and excess mortality in type 1 diabetes,” The New England Journal of Medicine, vol. 371, no. 21, pp. 1972–1982, 2014. View at Publisher · View at Google Scholar
  47. S. B. Pedersen, K. Kristensen, P. A. Hermann, J. A. Katzenellenbogen, and B. Richelsen, “Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 4, pp. 1869–1878, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. B. F. Palmer and D. J. Clegg, “The sexual dimorphism of obesity,” Molecular and Cellular Endocrinology, vol. 402, pp. 113–119, 2015. View at Google Scholar
  49. K. E. Davis, M. D. Neinast, K. Sun et al., “The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis,” Molecular Metabolism, vol. 2, no. 3, pp. 227–242, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. I. Janssen, L. H. Powell, S. Crawford, B. Lasley, and K. Sutton-Tyrrell, “Menopause and the metabolic syndrome: the study of Women's Health Across the Nation,” Archives of Internal Medicine, vol. 168, no. 14, pp. 1568–1575, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. I. Janssen, L. H. Powell, R. Kazlauskaite, and S. A. Dugan, “Testosterone and visceral fat in midlife women: the study of women's health across the nation (SWAN) fat patterning study,” Obesity, vol. 18, no. 3, pp. 604–610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Wang, P. S. Green, and J. W. Simpkins, “Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells,” Journal of Neurochemistry, vol. 77, no. 3, pp. 804–811, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. S. P. Duckles, D. N. Krause, C. Stirone, and V. Procaccio, “Estrogen and mitochondria: a new paradigm for vascular protection?” Molecular Interventions, vol. 6, no. 1, pp. 26–35, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. R. O'Lone, K. Knorr, I. Z. Jaffe et al., “Estrogen receptors α and β mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and generation of reactive oxygen species,” Molecular Endocrinology, vol. 21, no. 6, pp. 1281–1296, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Q. Chen, P. R. Cammarata, C. P. Baines, and J. D. Yager, “Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1793, no. 10, pp. 1540–1570, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Borrás, J. Gambini, R. López-Grueso, F. V. Pallardó, and J. Viña, “Direct antioxidant and protective effect of estradiol on isolated mitochondria,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1802, no. 1, pp. 205–211, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Sugishita, F. Li, Z. Su, and W. H. Barry, “Anti-oxidant effects of estrogen reduce [Ca2+]i during metabolic inhibition,” Journal of Molecular and Cellular Cardiology, vol. 35, no. 3, pp. 331–336, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. K. A. Mattingly, M. M. Ivanova, K. A. Riggs, N. S. Wickramasinghe, M. J. Barch, and C. M. Klinge, “Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis,” Molecular Endocrinology, vol. 22, no. 3, pp. 609–622, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. Y.-C. Hsieh, M. A. Choudhry, H.-P. Yu et al., “Inhibition of cardiac PGC-1α expression abolishes ERβ agonist-mediated cardioprotection following trauma-hemorrhage,” The FASEB Journal, vol. 20, no. 8, pp. 1109–1117, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. I. Gigli and L. E. Bussmann, “Exercise and ovarian steroid hormones: their effects on mitochondrial respiration,” Life Sciences, vol. 68, no. 13, pp. 1505–1514, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. D. H. Korzick, T. S. Lancaster, S. J. Jefferson et al., “Quantitative proteomic analysis reveals novel mitochondrial targets of estrogen deficiency in the aged female rat heart,” Physiological Genomics, vol. 44, no. 20, pp. 957–969, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Q. Chen, M. Delannoy, C. Cooke, and J. D. Yager, “Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 286, no. 6, pp. E1011–E1022, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Velickovic, A. Cvoro, B. Srdic et al., “Expression and subcellular localization of estrogen receptors α and β in human fetal brown adipose tissue,” Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 1, pp. 151–159, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. S.-H. Yang, R. Liu, E. J. Perez et al., “Mitochondrial localization of estrogen receptor β,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 12, pp. 4130–4135, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Milanesi, A. R. de Boland, and R. Boland, “Expression and localization of estrogen receptor alpha in the C2C12 murine skeletal muscle cell line,” Journal of Cellular Biochemistry, vol. 104, no. 4, pp. 1254–1273, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Q. Chen, M. Eshete, W. L. Alworth, and J. D. Yager, “Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors α and β to human mitochondrial DNA estrogen response elements,” Journal of Cellular Biochemistry, vol. 93, no. 2, pp. 358–373, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. M. I. Sanchez, A. M. Shearwood, T. Chia, S. M. Davies, O. Rackham, and A. Filipovska, “Estrogen-mediated regulation of mitochondrial gene expression,” Molecular Endocrinology, vol. 29, no. 1, pp. 14–27, 2015. View at Publisher · View at Google Scholar
  68. J. C. Bopassa, M. Eghbali, L. Toro, and E. Stefani, “A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 298, no. 1, pp. H16–H23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. T. R. Koves, J. R. Ussher, R. C. Noland et al., “Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance,” Cell Metabolism, vol. 7, no. 1, pp. 45–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. L. Zhang, W. Keung, V. Samokhvalov, W. Wang, and G. D. Lopaschuk, “Role of fatty acid uptake and fatty acid β-oxidation in mediating insulin resistance in heart and skeletal muscle,” Biochimica et Biophysica Acta, vol. 1801, no. 1, pp. 1–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. J. P. A. Cavalcanti-de-Albuquerque, I. C. Salvador, E. L. Martins et al., “Role of estrogen on skeletal muscle mitochondrial function in ovariectomized rats: a time course study in different fiber types,” Journal of Applied Physiology, vol. 116, no. 7, pp. 779–789, 2014. View at Publisher · View at Google Scholar · View at Scopus
  72. G. I. Shulman, “Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease,” The New England Journal of Medicine, vol. 371, no. 12, pp. 1131–1141, 2014. View at Publisher · View at Google Scholar
  73. G. Capllonch-Amer, M. Sbert-Roig, B. M. Galmés-Pascual et al., “Estradiol stimulates mitochondrial biogenesis and adiponectin expression in skeletal muscle,” Journal of Endocrinology, vol. 221, no. 3, pp. 391–403, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. D. F. Archer, “Tissue-selective eestrogen complexes: a promising option for the comprehensive management of menopausal symptoms,” Drugs & Aging, vol. 27, no. 7, pp. 533–544, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. J. H. Kim, M. S. Meyers, S. S. Khuder et al., “Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice,” Molecular Metabolism, vol. 3, no. 2, pp. 177–190, 2014. View at Publisher · View at Google Scholar
  76. J. Barrera, K. L. Chambliss, M. Ahmed et al., “Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 307, no. 3, pp. E345–E354, 2014. View at Publisher · View at Google Scholar
  77. B. Finan, B. Yang, N. Ottaway et al., “Targeted estrogen delivery reverses the metabolic syndrome,” Nature Medicine, vol. 18, no. 12, pp. 1847–1856, 2012. View at Publisher · View at Google Scholar · View at Scopus